
Austin Jabbour MD
Dermatology Resident Physician (PGY-2) at New York Medical College (Metropolitan) in New York, NY.
Join to View Full Profile
1901 1st AveNew York, NY 10029
Phone+1 212-423-7116
Fax+1 206-221-4364
Dr. Jabbour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Austin is currently a Dermatology Resident (PGY-2) at New York Medical College (Metropolitan) in New York, NY. He completed his PGY-1 training in internal medicine at SUNY Upstate Medical University in Syracuse, NY.
Education & Training
- New York Medical College (Metropolitan)Residency, Dermatology, 2024 - 2027
- SUNY Upstate Medical UniversityInternship, Internal Medicine, 2022 - 2023
- The University of Queensland Medical SchoolClass of 2021, MD
- State University of New York - College at GeneseoBS, Biology, 2012 - 2016
Awards, Honors, & Recognition
- Skin of Color Update 2024 Resident Scholarship Medscape LIVE!, 2024
- Sepsis Champion SUNY Upstate Medical University, 2023
- Certificate of Research Achievement University of Queensland School of Medicine, 2021
- Join now to see all
Clinical Trials
- T2Resistance - Detection of Resistance Related Genes Start of enrollment: 2022 Jan 21
- Adjuvant Avelumab in Merkel Cell Cancer Start of enrollment: 2017 Dec 19
- Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial Start of enrollment: 2018 Nov 15
- Join now to see all
Publications & Presentations
PubMed
- Merkel cell carcinoma-derived macrophage migration inhibitory factor (MIF) may promote persistence of Chronic Lymphocytic Leukemia.Gabriel F Alencar, Haroldo J Rodriguez, Thomas H Pulliam, Allison J Remington, Macy W Gilmour
Biorxiv. 2024-09-18 - 1 citationsMerkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy.Tomoko Akaike, Austin J Jabbour, Peter H Goff, Song Y Park, Shailender Bhatia
Journal for Immunotherapy of Cancer. 2024-07-24 - 4 citationsGenetic Risk Factors for Early-Onset Merkel Cell Carcinoma.Noreen Mohsin, Devin Hunt, Jia Yan, Austin J Jabbour, Paul Nghiem
JAMA Dermatology. 2024-02-01
Journal Articles
- Merkel cell carcinoma-derived macrophage migration inhibitory factor (MIF) may promote persistence of Chronic Lymphocytic Leukemia when both tumors are present in a ly...Alencar GF, Rodriguez HJ, Pulliam T, Remington AJ, Gilmour MW, Alam R, Jabbour AJ, DeBuysscher BL, Mullen LJ, Nghiem P, Taylor JJ, bioRxiv, 9/13/2024
Abstracts/Posters
- MAGT1 deficiency causes elevated risk for polyomavirus infections and development of early-onset MCPyV-positive Merkel cell carcinomaSaito Y, Mohsin N, Strong J, Jabbour AJ, Brownell I, American Academy of Dermatology (AAD) 2025, Orlando, FL, 3/2025
- Optimizing surgical training for the left-handed dermatology resident: A systematic review for identifying challenges and proposing guidelines for better education of ...Al-Dojaily Y, Jabbour AJ, Khachemoune A, The Dermatologic Society of Greater New York 2025 Annual Stritzler Resident Competition, New York, NY, 2/6/2025
- Clinical benefit of adding radiation in immunotherapy-refractory Merkel cell carcinoma among 41 patientsMenon A, Alam R, Jabbour AJ, Bhakuni R, Gooley T, Hippie D, Lachance K, Nghiem P, Society for Immunotherapy of Cancer (SITC) 2024, Houston, TX, 11/2024
- Join now to see all
Lectures
- Outcomes and implications of positive circulating tumor DNA in the absence of clinically evident disease: A review of 31 Merkel cell carcinoma patientsSeattle, WA - 5/28/2024
- Outcomes among 31 Merkel cell carcinoma patients with positive circulating tumor DNA but no clinically evident diseaseDallas, TX - 5/17/2024
- Optimizing Merkel Cell Carcinoma Care: The Role of Multidisciplinary Tumor BoardsHouston, TX - 5/3/2024
- Join now to see all
Press Mentions
- 2023 Merkel CELLebration DinnerSeptember 13th, 2023
- Nghiem Lab Welcomes Clinical Research Fellow Dr. Austin JabbourJuly 7th, 2023
- Ochsner Top Enroller in the U.S. for T2Resistance 510 (k) StudyApril 26th, 2023
- Join now to see all
Research History
- Research Fellow for Isaac Brownell, M.D., Ph.D., Dermatology Branch at the National Institutes of Health, Bethesda, MDInvestigated novel MAGT1 deficiency in patients with XMEN disease and early-onset Merkel cell carcinoma; facilitated a retrospective cohort analysis of EGFR inhibitor-associated skin toxicity; collaborated with physicians and international pharmaceutical companies with NIH-funded research studies2021 - Present
- Clinical Research Fellow, Non-ACGME, for Paul Nghiem, M.D., Ph.D., Department of Dermatology at the University of WashingtonCoordinated various NIH-funded clinical trials and outcomes projects investigating Merkel cell carcinoma; assisted in funding proposals for new trials; attended conferences and presented cutting-edge data from current projects; organized weekly multidisciplinary rounds and coordinated oncologic care2023 - 2024
- Clinical Research Associate for George Pankey, M.D., Institute of Translational Research at Ochsner Clinic Foundation, New Orleans, LACoordinated T2 Resistance Panel pharmaceutical-sponsored study that enrolled 1500 subjects across 10 clinical sites and streamlined scientific protocols to be utilized by the sponsor across all study sites. The study was funded by T2 Biosystems and data will be submitted to the FDA for clearance2022 - 2023
- Institutional Review Board (IRB) Alternate Member, Ochsner Health, New Orleans, LAResponsible for familiarizing IRB review panel with research proposals and consent forms in the absence of permanent IRB members and casting ballots in favor or against new and upcoming projects at Ochsner Health.2021 - 2022
- Research Assistant for Lynn Petukhova, Ph.D., Columbia University Medical Center, New York, NYSpearheaded professional relationship between Ochsner Health and Columbia University to facilitate exome and genome-wide association studies of HS patients from southern states; assisted with the patient consent process, collection of specimen, and analysis of data.2020 - 2021
- Research Assistant, Laboratory of Jenna Puccini, Ph.D., The University of Rochester Center for Neural Development and Disease, Rochester, NYPerformed various laboratory techniques, including daily culture maintenance, real-time PCR analyses, thin section staining with electron microscopy, and molecular tag assays of model organism stem cell lines.2015 - 2015
Professional Memberships
- Member
- Medical Dermatology SocietyMember
- Medical Society of the State of New YorkMember
- Member
- American Society for Laser Medicine and Surgery - ASLMSMember
- Member
External Links
- New York Medical College (Metropolitan)https://www.nymc.edu/som/education/gme/nymc-residency-programs/dermatology-residency-at-metropolitan/residents/first-year-residents/jabbour-austin-j.php
- ORCIDhttps://orcid.org/0000-0003-4835-7597
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: